252 related articles for article (PubMed ID: 23973251)
1. SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.
Shiroma PR; Drews MS; Geske JR; Mrazek DA
Am J Geriatr Psychiatry; 2014 Nov; 22(11):1140-8. PubMed ID: 23973251
[TBL] [Abstract][Full Text] [Related]
2. SLC6A4 variation and citalopram response.
Mrazek DA; Rush AJ; Biernacka JM; O'Kane DJ; Cunningham JM; Wieben ED; Schaid DJ; Drews MS; Courson VL; Snyder KA; Black JL; Weinshilboum RM
Am J Med Genet B Neuropsychiatr Genet; 2009 Apr; 150B(3):341-51. PubMed ID: 18618621
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes for older depressed patients with earlier versus late onset of first depressive episode: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.
Kozel FA; Trivedi MH; Wisniewski SR; Miyahara S; Husain MM; Fava M; Lebowitz B; Zisook S; Rush AJ
Am J Geriatr Psychiatry; 2008 Jan; 16(1):58-64. PubMed ID: 18165462
[TBL] [Abstract][Full Text] [Related]
4. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
Hu XZ; Rush AJ; Charney D; Wilson AF; Sorant AJ; Papanicolaou GJ; Fava M; Trivedi MH; Wisniewski SR; Laje G; Paddock S; McMahon FJ; Manji H; Lipsky RH
Arch Gen Psychiatry; 2007 Jul; 64(7):783-92. PubMed ID: 17606812
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failure.
Ahmed AT; Biernacka JM; Jenkins G; Rush AJ; Shinozaki G; Veldic M; Kung S; Bobo WV; Hall-Flavin DK; Weinshilboum RM; Wang L; Frye MA
J Affect Disord; 2019 Mar; 246():62-68. PubMed ID: 30578947
[TBL] [Abstract][Full Text] [Related]
6. Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample.
Kraft JB; Peters EJ; Slager SL; Jenkins GD; Reinalda MS; McGrath PJ; Hamilton SP
Biol Psychiatry; 2007 Mar; 61(6):734-42. PubMed ID: 17123473
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.
Rush AJ; Bernstein IH; Trivedi MH; Carmody TJ; Wisniewski S; Mundt JC; Shores-Wilson K; Biggs MM; Woo A; Nierenberg AA; Fava M
Biol Psychiatry; 2006 Mar; 59(6):493-501. PubMed ID: 16199008
[TBL] [Abstract][Full Text] [Related]
8. The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort.
Lekman M; Laje G; Charney D; Rush AJ; Wilson AF; Sorant AJ; Lipsky R; Wisniewski SR; Manji H; McMahon FJ; Paddock S
Biol Psychiatry; 2008 Jun; 63(12):1103-10. PubMed ID: 18191112
[TBL] [Abstract][Full Text] [Related]
9. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.
Nierenberg AA; Husain MM; Trivedi MH; Fava M; Warden D; Wisniewski SR; Miyahara S; Rush AJ
Psychol Med; 2010 Jan; 40(1):41-50. PubMed ID: 19460188
[TBL] [Abstract][Full Text] [Related]
10. Do menopausal status and use of hormone therapy affect antidepressant treatment response? Findings from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study.
Kornstein SG; Toups M; Rush AJ; Wisniewski SR; Thase ME; Luther J; Warden D; Fava M; Trivedi MH
J Womens Health (Larchmt); 2013 Feb; 22(2):121-31. PubMed ID: 23398127
[TBL] [Abstract][Full Text] [Related]
11. Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.
Maron E; Tammiste A; Kallassalu K; Eller T; Vasar V; Nutt DJ; Metspalu A
Eur Neuropsychopharmacol; 2009 Jun; 19(6):451-6. PubMed ID: 19272758
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcomes of depression: the pharmacogenomic research network antidepressant medication pharmacogenomic study.
Mrazek DA; Biernacka JM; McAlpine DE; Benitez J; Karpyak VM; Williams MD; Hall-Flavin DK; Netzel PJ; Passov V; Rohland BM; Shinozaki G; Hoberg AA; Snyder KA; Drews MS; Skime MK; Sagen JA; Schaid DJ; Weinshilboum R; Katzelnick DJ
J Clin Psychopharmacol; 2014 Jun; 34(3):313-7. PubMed ID: 24743713
[TBL] [Abstract][Full Text] [Related]
13. Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.
Binder EB; Owens MJ; Liu W; Deveau TC; Rush AJ; Trivedi MH; Fava M; Bradley B; Ressler KJ; Nemeroff CB
Arch Gen Psychiatry; 2010 Apr; 67(4):369-79. PubMed ID: 20368512
[TBL] [Abstract][Full Text] [Related]
14. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.
Perlis RH; Purcell S; Fava M; Fagerness J; Rush AJ; Trivedi MH; Smoller JW
Arch Gen Psychiatry; 2007 Jun; 64(6):689-97. PubMed ID: 17548750
[TBL] [Abstract][Full Text] [Related]
15. Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report.
Gilmer WS; Gollan JK; Wisniewski SR; Howland RH; Trivedi MH; Miyahara S; Fleck J; Thase ME; Alpert JE; Nierenberg AA; Warden D; Fava M; Rush AJ
J Clin Psychiatry; 2008 Aug; 69(8):1246-56. PubMed ID: 18681756
[TBL] [Abstract][Full Text] [Related]
16. Trajectories of individual symptoms in remitters versus non-remitters with depression.
Sakurai H; Uchida H; Abe T; Nakajima S; Suzuki T; Pollock BG; Sato Y; Mimura M
J Affect Disord; 2013 Nov; 151(2):506-513. PubMed ID: 23886402
[TBL] [Abstract][Full Text] [Related]
17. Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder.
Garriock HA; Tanowitz M; Kraft JB; Dang VC; Peters EJ; Jenkins GD; Reinalda MS; McGrath PJ; von Zastrow M; Slager SL; Hamilton SP
Am J Psychiatry; 2010 May; 167(5):565-73. PubMed ID: 20194481
[TBL] [Abstract][Full Text] [Related]
18. Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D.
Gaynes BN; Rush AJ; Trivedi MH; Wisniewski SR; Balasubramani GK; McGrath PJ; Thase ME; Klinkman M; Nierenberg AA; Yates WR; Fava M
J Gen Intern Med; 2008 May; 23(5):551-60. PubMed ID: 18247097
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
Trivedi MH; Rush AJ; Wisniewski SR; Nierenberg AA; Warden D; Ritz L; Norquist G; Howland RH; Lebowitz B; McGrath PJ; Shores-Wilson K; Biggs MM; Balasubramani GK; Fava M;
Am J Psychiatry; 2006 Jan; 163(1):28-40. PubMed ID: 16390886
[TBL] [Abstract][Full Text] [Related]
20. Ethnicity/race and outcome in the treatment of depression: results from STAR*D.
Lesser IM; Castro DB; Gaynes BN; Gonzalez J; Rush AJ; Alpert JE; Trivedi M; Luther JF; Wisniewski SR
Med Care; 2007 Nov; 45(11):1043-51. PubMed ID: 18049344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
